fashion -WSS

fashion

author：leisure time 2025-09-06 08:39:44 - browse：9782

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Why drug prescriptions should include diagnoses

leisure time

WSS

Why Novartis is changing the name of its research labs

Gene therapy has helped boys walk. Can scientists keep it that way?

What drug price negotiations mean for Medicare Part D

What drug price negotiations mean for Medicare Part D

The battle over the Brookhaven Landfill on Long Island

Covid hospitalizations on the rise, Humana says

focus

fashion

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Donald Trump's relentless attacks on special counsel Jack Smith

Continuity nursing helped my family in our darkest PICU moments

How to fix cancer clinical trials' diversity problem

The cancer drug shortage isn’t new — and neither are the solutions

In areas with more Black doctors, Black people live longer

Alkermes shareholders re

The battle over the Brookhaven Landfill on Long Island

Peter Hotez and the public health issue of online harassment

New guidelines on severe brain injury complicate already difficult decisions

entertainment

Amazon on where the company's health care bets are headed next

The strategy behind pharma's lawsuits over drug pricing reform

Ask STAT: What do you want to know about ChatGPT in medicine?

Gene therapy has helped boys walk. Can scientists keep it that way?

Why Novartis is changing the name of its research labs

Do masks work? RCTs can't tell us

leisure time

knowledge

focus

knowledge